Endogenous Interleukin-33 Acts as an Alarmin in Liver Ischemia-Reperfusion and Is Associated With Injury After Human Liver Transplantation.

MLA

Barbier, Louise, et al. “Endogenous Interleukin-33 Acts as an Alarmin in Liver Ischemia-Reperfusion and Is Associated With Injury After Human Liver Transplantation.” Frontiers in Immunology, vol. 12, Sept. 2021, p. 744927. EBSCOhost, https://doi.org/10.3389/fimmu.2021.744927.

APA

Barbier, L., Robin, A., Sindayigaya, R., Ducousso, H., Dujardin, F., Thierry, A., Hauet, T., Girard, J.-P., Pellerin, L., Gombert, J.-M., Herbelin, A., & Salamé, E. (2021). Endogenous Interleukin-33 Acts as an Alarmin in Liver Ischemia-Reperfusion and Is Associated With Injury After Human Liver Transplantation. Frontiers in Immunology, 12, 744927. https://doi.org/10.3389/fimmu.2021.744927

Chicago

Barbier, Louise, Aurélie Robin, Rémy Sindayigaya, Héloïse Ducousso, Fanny Dujardin, Antoine Thierry, Thierry Hauet, et al. 2021. “Endogenous Interleukin-33 Acts as an Alarmin in Liver Ischemia-Reperfusion and Is Associated With Injury After Human Liver Transplantation.” Frontiers in Immunology 12 (September): 744927. doi:10.3389/fimmu.2021.744927.